Therapeutic Innovation & Regulatory Science (TIRS): Focus on Pharmaceutical Compounding

April 4, 2016

Develop. Innovate. Advance. DIA is the only global organization dedicated to bringing health care product development professionals together in a neutral environment to improve health and well-being throughout the world. - See more at:

Pharmaceutical compounding is an essential aspect of medicine in the US, although with inherent risks that must be understood and managed. In May 2016, the Special Section of TIRS overviews the history of compounding, identifies the special challenges associated with the practice, and offers improvements for patient safety.

Read more here.